Project Grant R21HD116236

Award Date 8/1/24
Completion Date 7/31/26
Dollars Obligated $390K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
William Penn Annex West, PA 19107, USA
Similar Awards
This $107,860 Project Grant, awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to understand the functional role of fibroid subtype mutations in developing new targeted therapies for uterine fibroids. The research aims to 1) determine the functional roles of HMGA2 over-expression and MED12 mutation in uterine fibroids, 2) predict and test drug compounds to target...
The National Institute of Child Health and Human Development (NICHD) awarded a $429,000 Project Grant (CFDA 93.865: Child Health and Human Development Extramural Research) to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to develop a new imaging tool to assess placental hemodynamics during pregnancy. The study aims to determine if Subharmonic Aided Pressure Estimation (SHAPE) using contrast-enhanced ultrasound can provide a safe, non-invasive, and real-time method...
This National Science Foundation (NSF) Project Grant award under the Engineering program (CFDA 47.041) provides $199,930 to the University of Chicago to assess microbubble-induced stresses on soft materials like tissue, in order to support the development of regulatory guidelines for bubble-based medical devices like therapeutic ultrasound systems. The key objectives are to: 1) develop and characterize a mechanophore-based tissue phantom to quantify microbubble-induced deformation, 2)...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $229,393 to the University of North Carolina at Chapel Hill (UNC-CH) to conduct research on the relationship between early life adversities and the risk of uterine fibroids among Black/African American women. The key products and services to be delivered include: 1) describing the prevalence and...
The National Science Foundation's (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $274,975 Project Grant to Worcester Polytechnic Institute (WPI) under the NSF Engineering program (CFDA 47.041) to investigate the role of microbubbles in improving the efficacy of high-intensity focused ultrasound (HIFU) therapy. The key objectives are to develop a well-controlled in vitro experimental setup to study temperature elevation in tissue phantoms with and...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $1,624,100 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to conduct research on the role of REST and MED12, two key tumor suppressor molecules, in regulating estrogen-progesterone pathways in uterine fibroids. The project aims to define molecular hallmarks that could lead to the development of selective...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $202,076 Project Grant (R21EB035809) to Weill Medical College of Cornell University to develop quantitative ultrasound (QUS) imaging methods for non-invasive characterization of white adipose tissue (WAT) microstructure in vivo. The research aims to validate QUS as a technique to measure adipocyte size, number density, and spatial organization, and to demonstrate QUS's ability to detect localized microstructural...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $365,523 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Georgia Tech Research Corporation to conduct research on using ultrasound imaging to track macrophage trafficking in tissue. The key objectives are to: Determine the detection limit of macrophages labeled with ultrasound contrast agents (microbubbles) under different ultrasound...
This federal Project Grant award for $599,191, provided by the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research program), supports the development and validation of a 3D dynamic contrast-enhanced ultrasound (3D DCE-US) framework to characterize tumor vascular properties for liver malignancies. The goal is to introduce computational approaches that leverage the interconnected nature of voxels in 3D DCE-US imaging to capture new information beyond conventional...
This R01 project grant, awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is developing a Transcranial Magnetic Resonance (MR) and Ultrasound (US) Guided Histotripsy (TCMR-USGHT) system for the non-invasive treatment of brain tumors. The $543,959 award, with a period of performance from January 15, 2025 to December 31, 2028, supports the...

EVALUATION OF UTERINE FIBROIDS BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND SUBHARMONIC-AIDED PRESSURE ESTIMATION (SHAPE) PRE AND POST UTERINE ARTERY EMBOLIZATION (UAE) - UTERINE FIBROIDS AFFECT APPROXIMATELY 30% OF ALL WOMEN IN THE UNITED STATES OR ABOUT 45 MILLION INDIVIDUALS. THE CLINICAL DIAGNOSIS OF UTERINE FIBROIDS IS TWO TO THREE TIMES MORE COMMON IN AFRICAN- AMERICAN WOMEN THAN IN CAUCASIAN WOMEN. UTERINE ARTERY EMBOLIZATION (UAE) IS A NONSURGICAL THERAPY THAT SHRINKS FIBROIDS BY BLOCKING ARTERIAL BLOOD FLOW TO THE LESIONS. PRIOR TO THE UAE PROCEDURE ALMOST ALL PATIENTS RECEIVE A CONTRAST-ENHANCED MRI, WHICH IS CURRENTLY CONSIDERED THE REFERENCE IMAGING METHOD. AFTER THE UAE, THE CURRENT STRATEGY IS TO REQUEST A CONTRAST-ENHANCED MRI TO EVALUATE THE EFFICACY OF THE TREATMENT. HOWEVER, AN MRI IS NOT ALWAYS AVAILABLE AND REMAINS VERY EXPENSIVE. ULTRASOUND IMAGING OFFERS A LOW COST, NON-INVASIVE, AND READILY AVAILABLE APPROACH, WHICH CAN CHARACTERIZE BOTH STRUCTURAL AND FUNCTIONAL FEATURES OF TUMOR VASCULARITY FROM ITS EARLIEST STAGES. MOREOVER, MICROBUBBLE-BASED ULTRASOUND CONTRAST AGENTS (UCA) NOT ONLY ENHANCE THE BACKSCATTERED SIGNALS, BUT AT HIGHER ACOUSTIC PRESSURES THEY ALSO ACT AS NONLINEAR OSCILLATORS PRODUCING SIGNIFICANT ENERGY COMPONENTS IN THE RECEIVED ECHO SIGNALS. THESE NONLINEAR BUBBLE ECHOES CAN BE SEPARATED FROM TISSUE ECHOES AND USED TO CREATE CONTRAST SPECIFIC ULTRASOUND IMAGING MODALITIES (E.G., HARMONIC IMAGING; HI). HI PREFERENTIALLY ENHANCES AND DISPLAYS CONTRAST SIGNALS RATHER THAN SURROUNDING TISSUE ECHOES BY TRANSMITTING AT THE FUNDAMENTAL TRANSDUCER FREQUENCY (F0) AND RECEIVING AT THE SECOND HARMONIC (2F0). HI IS COMMERCIALLY AVAILABLE ON MOST STATE-OF-THE-ART ULTRASOUND SCANNERS. OUR GROUP DEVELOPED THE FUNDAMENTAL CONCEPT OF CONTRAST-ENHANCED SUBHARMONIC-AIDED PRESSURE ESTIMATION (SHAPE). THIS APPROACH RELIES ON USING THE INVERSE LINEAR RELATIONSHIP BETWEEN SUBHARMONIC SIGNALS FROM UCA AND THE AMBIENT PRESSURES. THEREFORE, WE BELIEVE THAT DEVELOPMENT OF SHAPE AS AN ACCURATE NONINVASIVE TECHNIQUE FOR MEASUREMENT OF AMBIENT PRESSURE CAN BE TRANSLATED FOR THE EVALUATION OF UTERINE FIBROIDS PRESSURES IN ORDER TO ESTABLISH PARAMETERS FOR DYNAMIC EVALUATION. THUS, THIS STUDY GOALS ARE TO DETERMINE THE PATTERNS OF UTERINE FIBROID VASCULARITY PRE AND POST UAE USING CEUS RESULTING IN AN ALTERNATIVE TO GADOLINIUM-ENHANCED MRI THAT IS LESS EXPENSIVE, HAS LESS CONTRA-INDICATIONS AND SIDE EFFECTS, IS REAL TIME, AND NONINVASIVE HELPING PHYSICIANS TO EVALUATE THE RESULT OF UAE PROCEDURES. ALSO, THIS STUDY WILL EVALUATE UTERINE FIBROID PRESSURES USING SHAPE, COMPARING THE RESULTS WITH NORMAL MYOMETRIUM TISSUE IN ORDER TO DETERMINE ITS CHARACTERISTICS AND TISSUE DIFFERENCES, WHICH WE BELIEVE WILL LEAD TO THE DEVELOPMENT OF A NEW BIOMARKER FOR THE DIAGNOSIS AND TREATMENT OF UTERINE FIBROIDS.

Posted 7/31/24, 12:00 AM